Professor Lam leads a team of multi-skilled researchers in the following cancer studies:
There is evidence that research contributes directly to improve the care of patients with colorectal cancer by more accurately refining prognosis and selecting the most appropriate adjuvant therapy for individual patients with colorectal carcinoma. In order to do this, our research focuses on studying novel tissue-based prognostic indicators at the molecular level.
Thyroid cancer and endocrine tumors molecular pathology
Endocrine tumours affect mainly females and may have significant systemic effects. The morphologies of these cancers are diverse and making a definite diagnosis often needs the works of specialists. In addition, the behavior of these lesions may not be predicted by clinicopathological features. Professor Lam and his team work on genetic profiles, pathological classification and prognostic markers studies in thyroid and other endocrine lesions.Colorectal cancer molecular pathology
Colorectal cancer is amongst the most common malignancy found in the Western world and usually ranks high in incidence and mortality among malignancies in those countries. Globally, colorectal cancers accounted for about 1 million new cases.There is evidence that research contributes directly to improve the care of patients with colorectal cancer by more accurately refining prognosis and selecting the most appropriate adjuvant therapy for individual patients with colorectal carcinoma. In order to do this, our research focuses on studying novel tissue-based prognostic indicators at the molecular level.